降压1号治疗老年原发性高血压伴失眠临床研究

目的：探讨降压1号治疗老年原发性高血压伴失眠的临床效果,为其临床应用提供参考依据.方法：选取老年原发性高血压伴失眠患者80例,随机将其分成治疗组和对照组,每组40例,治疗组患者采用降压1号治疗,对照组患者采用氯沙坦钾和艾司唑仑治疗.治疗结束后,观察比较两组患者的临床治疗有效率、汉密尔顿焦虑量表（HAMA）以及睡眠障碍量表（SDRS）评分情况.结果：经过治疗,治疗组患者总有效率为95.0％,显著高于对照组的80.0％,两组比较差异具有统计学意义（P＜0.05）;两组患者治疗前后HAMA、SDRS评分及血压均差异显著（P＜0.05）;治疗后组间SDRS评分比较差异显著,具有统计学意义（P＜0.05）.结论：降压1号可有效改善原发性高血压伴失眠症状,控制患者血压,改善患者睡眠质量,值得临床推广应用.

Research on Efficacy of Hypertension No.1 on Elderly Essential Hypertension and Insomnia

Objective： To investigate efficacy research of Hypertension No. 1 on elderly essential hypertension and insomnia. Methods：80 cases of elderly essential hypertension and insomnia patients were selected and randomly divided into treatment group and control group, each 40 cases. Patients in treatrnent group were given Hypertension No. 1, and patients in control group were given losartan potassium and estazolam. After treatment, clinical efficient, Hamilton Anxiety Scale （HAMA） and Sleep Disorder Scale （SDRS） score of two groups were observed and compared. Results： Effective rate of treatment group was 95 %, which was significantly higher than that of control group （80%）, the difference was statistically significant （P〈0.05）; HAMA and SDRS scores of two groups before and after treatment had statistically significant differences （P〈0. 05）; HAMA and SDRS scores of treatment group were significantly better than that of control group （P〈 0. 05）. Conclusion. Hypertension No. 1 can effectively treat elderly essential hypertension and insomnia, control blood pressure, and improve sleep quality, worthy of promotion.